Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04583709 · ClinicalTrials.gov registry record · NA
ECG Belt to Assess Electrical Synchronization
A NA study of Heart Failure and Bradycardia, sponsored by Pugazhendhi Vijayaraman.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04583709: Completed NA study of Heart Failure and Bradycardia, sponsored by Pugazhendhi Vijayaraman.
NCT04583709 is a NA study of Heart Failure and Bradycardia that has completed, run by Pugazhendhi Vijayaraman. The registered enrollment target is 20 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04583709, a NA study of Heart Failure and Bradycardia, has completed, sponsored by Pugazhendhi Vijayaraman.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to assess the utility of ECG Belt to understand the conduction and ECG characteristics of Left Bundle Branch Pacing (LBBAP) and His-Optimized Cardiac Resynchronization Therapy (HOT-CRT) and compare with preexisting data in traditional Cardiac Resynchronization Therapy (CRT) and Right Ventricular Pacing (RVP).
Primary Outcome
Change in SDAT following LBBP measured in ms using ECG Belt
Conditions Studied
Interventions
- DEVICE ECG Belt
Study Locations (1)
Pennsylvania
- Geisinger Wyoming Valley - Wilkes-Barre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-01-13 |
| Est. Completion | 2021-06-25 |
| Phase | NA |
What the finished NCT04583709 record still lists
NCT04583709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which ECG Belt is the first listed.
NCT04583709 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04583709 about?
NCT04583709 is a clinical study titled "ECG Belt to Assess Electrical Synchronization". The objective of the study is to assess the utility of ECG Belt to understand the conduction and ECG characteristics of Left Bundle Branch Pacing (LBBAP) and His-Optimized Cardiac Resynchronization Therapy (HOT-CRT) and compare with preexisting data in traditional Cardiac Resynchronization Therapy (...
What is the current status of trial NCT04583709?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-01-13. Estimated completion is 2021-06-25.
What conditions does trial NCT04583709 study?
This clinical trial studies the following conditions: Heart Failure, Bradycardia.
What interventions are being tested in trial NCT04583709?
The interventions under investigation include: ECG Belt (DEVICE).
Who is sponsoring clinical trial NCT04583709?
This trial is sponsored by Pugazhendhi Vijayaraman, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04583709 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04583709's enrollment target sits among peer trials
20 350th of 397 higher than 37 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI